本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BriaCell Therapeutics Corp.

4.13
-0.0797-1.89%
成交量:2.59萬
成交額:10.77萬
市值:3,593.28萬
市盈率:-0.43
高:4.17
開:4.16
低:4.10
收:4.21
52周最高:14.68
52周最低:2.60
股本:869.98萬
流通股本:785.96萬
量比:0.87
換手率:0.33%
股息:- -
股息率:- -
每股收益(TTM):-9.6592
每股收益(LYR):-62.1862
淨資產收益率:-175.25%
總資產收益率:-90.84%
市淨率:1.49
市盈率(LYR):-0.07

資料載入中...

2021/03/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/18

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/02/18

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/18

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/18

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/03

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/02/02

SEC問詢函

CORRESP [Cover] - Correspondence
2021/01/15

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/01/14

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/23

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/12/22

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/10

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/12/10

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/20

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/10/20

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/18

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/05/27

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/05/27

SEC問詢函

CORRESP [Cover] - Correspondence